Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study
Titel:
Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study
Auteur:
Woo, Jong Shin Hong, Soon Jun Cha, Dong Hoon Kim, Kee Sik Kim, Moo Hyun Lee, Jun-Won Jeong, Myung Ho Jeong, Jin-Ok Lee, Jun-Hee Jeon, Doo Soo Cho, Eun Joo Kim, Soon Kil Kwan, Jun Park, Chang Gyu Lee, Hae Young Hong, Taek Jong Shin, Jinho Youn, Ho Joong Jeon, Dong Woon Chung, Wook Jin Jeong, Ju Cheol Kim, Chong Jin